Stonebridge Capital Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-662
Closed -$41.6K – 573
2023
Q3
$41.6K Sell
662
-87
-12% -$5.42K ﹤0.01% 384
2023
Q2
$42.3K Buy
749
+155
+26% +$8.6K ﹤0.01% 394
2023
Q1
$34.4K Buy
594
+2
+0.3% +$135 ﹤0.01% 420
2022
Q4
$42.8K Buy
592
+2
+0.3% +$143 0.01% 375
2022
Q3
$36K Buy
590
+51
+9% +$3.26K ﹤0.01% 380
2022
Q2
$34K Buy
539
+2
+0.4% +$132 ﹤0.01% 411
2022
Q1
$38K Buy
537
+2
+0.4% +$135 ﹤0.01% 426
2021
Q4
$33K Buy
535
+255
+91% +$16K ﹤0.01% 433
2021
Q3
$17K Hold
280
– – ﹤0.01% 526
2021
Q2
$17K Hold
280
– – ﹤0.01% 535
2021
Q1
$17K Buy
+280
New +$15.5K ﹤0.01% 534
2020
Q3
– Sell
-488
Closed -$18K – 487
2020
Q2
$18K Hold
488
– – ﹤0.01% 417
2020
Q1
$15K Hold
488
– – ﹤0.01% 430
2019
Q4
$25K Hold
488
– – ﹤0.01% 419
2019
Q3
$23K Hold
488
– – ﹤0.01% 426
2019
Q2
$24K Buy
+488
New +$22.9K ﹤0.01% 426

Other funds holding MET

Stonebridge Capital Advisors's MET Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of MetLife (MET) in Q4 2023, closing a stake of 662 shares — an estimated $41.6K sold.

Stonebridge Capital Advisors first reported a position in MET in Q2 2019 and held it in 16 quarters. The position peaked at $42.8K in Q4 2022. 1,262 funds tracked by Wall St. Rank hold MET as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining MetLife position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 662 MetLife shares in Q4 2023, an estimated $41.6K.
  • Stonebridge Capital Advisors first reported a position in MetLife in Q2 2019 and held it in 16 quarters.
  • Stonebridge Capital Advisors's MetLife position peaked at $42.8K in Q4 2022.
  • 1,262 funds tracked by Wall St. Rank held MetLife as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.